Our Mission & Vision
Driven by Science. Inspired by Healing.
At JY BioMed, we believe that the future of medicine lies in the convergence of biology, engineering, and a deep understanding of the human body’s innate healing potential. As a preclinical-stage biotechnology company, we are committed to advancing innovative cell-based and exosome therapies that lay the foundation for tomorrow’s treatments.
Mission
To transform scientific discoveries into scalable, safe, and accessible solutions that support tissue regeneration, immune balance, and disease modulation.
Our work centers on building robust, regulatory-ready platforms—from mesenchymal stem cells to gamma delta T cells and antibody-drug conjugates—that may one day offer meaningful benefits for patients facing serious medical challenges.
We collaborate with academic institutions, manufacturing partners, and research hospitals to ensure that every innovation is grounded in evidence, driven by purpose, and built for real-world impact.
Vision
To empower the global shift toward precision, cell-based healthcare by reimagining how complex diseases are approached—from the inside out.
We envision a future where advanced biologics—tailored to immune profiles and delivered with precision—can become part of everyday care, not just exceptional cases. Through relentless research, scalable technologies, and ethical development, JY BioMed aims to help shape a world where longevity is not only possible, but equitable.
Legal & Regulatory Note
Except for the umbilical cord-derived mesenchymal stem cell (UC-MSC) platform currently under Phase 1 clinical evaluation in Taiwan, all other platforms and technologies described herein remain under preclinical development and have not been approved for clinical or commercial use in any country.
